Archived COA Reference The previous Retatrutide 20mg COA is retained as an archived reference for transparency
Safer, Evidence-Based Alternatives to Dual-Medication Protocols Instead of combining Wegovy and phentermine, patients with inadequate response to monotherapy have several evidence-supported options
For patients already receiving chronic outpatient loop diuretics, the recommended starting intravenous (IV) dose is approximately 2.5 times their home oral furosemide dose
Compounded versions used in research settings should still be approached with appropriate medical guidance
Tirzepatide stands out from other weight loss medications, including Semaglutide GLP-1, due to its unique dual-action mechanism
This dual mechanism helps people feel full longer and keeps blood sugar more stable, making it a powerful tool for weight loss